NOVELION THERAPEUTICS INC's ticker is NVLNF and the CUSIP is 67001K202. A total of 80 filers reported holding NOVELION THERAPEUTICS INC in Q4 2017. The put-call ratio across all filers is 2.18 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2018 | $103,000 | -19.5% | 34,828 | 0.0% | 0.00% | -33.3% |
| Q2 2018 | $128,000 | +4.9% | 34,828 | 0.0% | 0.00% | 0.0% |
| Q1 2018 | $122,000 | +11.9% | 34,828 | 0.0% | 0.00% | +50.0% |
| Q4 2017 | $109,000 | -55.5% | 34,828 | 0.0% | 0.00% | -60.0% |
| Q3 2017 | $245,000 | -23.7% | 34,828 | 0.0% | 0.01% | 0.0% |
| Q2 2017 | $321,000 | -14.2% | 34,828 | 0.0% | 0.01% | -16.7% |
| Q1 2017 | $374,000 | +15.1% | 34,828 | -9.7% | 0.01% | +20.0% |
| Q4 2016 | $325,000 | – | 38,582 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Healthcare Value Capital, LLC | 1,313,387 | $4,833,000 | 13.70% |
| Stonepine Capital Management, LLC | 1,792,911 | $6,598,000 | 4.01% |
| Broadfin Capital, LLC | 1,948,554 | $7,171,000 | 1.13% |
| Sarissa Capital Management LP | 1,025,000 | $3,772,000 | 0.76% |
| JW Asset Management, LLC | 315,979 | $1,163,000 | 0.74% |
| Prosight Management, LP | 194,663 | $716,000 | 0.52% |
| ARMISTICE CAPITAL, LLC | 1,856,000 | $6,830,000 | 0.45% |
| KNOTT DAVID M | 109,184 | $402,000 | 0.15% |
| EdgePoint Investment Group Inc. | 2,195,063 | $8,078,000 | 0.10% |
| Yakira Capital Management, Inc. | 36,428 | $134,000 | 0.03% |